Retour aux projets

17485.1 PFLS-LS

Anti-MAG Neuropathy: Development of a Therapeutic Glycopolymer

Résumé

Anti-MAG Neuropathy: Development of a Therapeutic Glycopolymer

Textes supplémentaires

Abstract

The aim of this project is to define preclinical lead candidates for the treatment of anti-myelin-associated|glycoprotein (MAG) neuropathy, a disabling IgM autoantibody-mediated autoimmune disorder of the|peripheral nervous system. Currently, there is no effective treatment and agents to block/deplete the|pathogenic autoantibodies are of substancial clinical interest. Several lead candidates (glycopolymers) will|be synthesized and evaluated in an animal model of the disease.

Participants

Ruben Herrendorf

Wirtschaftspartner

ruben.herrendorff@unibas.ch

Polyneuron Pharmaceuticals AG Ruben Herrendorf Hochbergerstrasse 60c 4057 Basel BS CH

Beat Ernst

Kontaktperson

beat.ernst@unibas.ch

Universität Basel Beat Ernst Klingelbergstrasse 50 4056 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-03-31
Date de fin
2017-09-30
Coûts totaux approuvés
CHF 418900.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%